Kennedy Keith 4
4 · CareDx, Inc. · Filed Apr 22, 2026
Research Summary
AI-generated summary of this filing
CareDx (CDNA) CFO/COO Keith Kennedy Receives RSU Award
What Happened
- Keith Kennedy, Chief Financial Officer and Chief Operating Officer of CareDx, received a grant of 24,134 restricted stock units (RSUs) reported on 2026-04-20. The reported acquisition price is $0 (award). These RSUs do not represent immediately vested shares and will convert to common stock only as they vest.
Key Details
- Transaction date: 2026-04-20; Form 4 filed 2026-04-22 (timely filing).
- Type: Award/Grant (code A); acquisition price: $0.
- Shares reported: 24,134 RSUs granted.
- Shares owned after transaction: not specified in the filing.
- Footnote: RSUs vest one-third on April 6, 2027, with the remaining two-thirds vesting in equal quarterly installments over the next eight quarters (rounded down to whole shares), resulting in 100% vesting by the third anniversary of April 6, 2027 (i.e., April 6, 2030), subject to continuous employment.
- No tax withholding, 10b5-1 plan, or immediate sale noted in the filing.
Context
- RSUs are a form of equity compensation that convert into shares only when they vest; this grant does not indicate an immediate market transaction. Such awards are common for executive compensation and align pay with future service and company performance.
Insider Transaction Report
Form 4
CareDx, Inc.CDNA
Kennedy Keith
CFO & COO
Transactions
- Award
Common Stock
[F1]2026-04-20+24,134→ 221,548 total
Footnotes (1)
- [F1]The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the RSUs will be vested on the third anniversary of April 6, 2027, subject to the Reporting Person's continuous employment on each applicable vesting date.
Signature
/s/ Jeffrey Adam Novack, Attorney-in-Fact|2026-04-22